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Abstract  
Hemophilia a genetic disorder with patient’s inability to stop bleeding. There are two 
main types of hemophilia, hemophiliaA due to not enough clotting factor VIII and 
hemophilia B due to not enough factor IX,and acquired hemophilia A(AHA) caused by 
autoantibodies against clotting factor VIII(FVIII).AHA is associated with 
malignancy,autoimmune disorders, and pregnancy. Factor IX deficiency can cause 
interference of the coagulation cascade. People with more severe hemophilia usually 
suffer more severe and more bleeds than people with mild hemophilia. Complications of 
hemophilia include deep internal bleeding, joint damage, transfusion induced infection, 
adverse reactions to clotting factor treatment, and intracranial hemorrhage. Diagnosis 
of hemophilia can be confirmed by, coagulation screening test, bleeding scores and 
coagulation factor assay. Gold standard of treatment is rapid treatment of bleeding 
episodes decreases damage to the body.Prophylactic treatment although high costs, is 
more effective than on demand treatment. People with severe hemophilia without 
adequate treatment have generally shortened lifespans. Gene therapy is not currently 
an accepted treatment for hemophilia. 
